Lungs News and Research

RSS

Penn Medicine receives $9 million to advance research on imaging technology that illuminates tumors

Building on Penn Medicine's years of research and use of imaging technology that illuminates tumor tissue-; helping clinicians more easily detect and remove it-; the Perelman School of Medicine at the University of Pennsylvania has received a five-year, $9 million research grant from the National Cancer Institute (NCI) to push the field forward, particularly for lung cancer patients.

28 Jun 2022

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

A recent study posted to the bioRxiv* preprint server assessed whether niclosamide could be employed in coronavirus disease 2019 (COVID-19) therapy.

28 Jun 2022

Researchers identify an epigenetic signature associated to the development of MIS-C after COVID-19

Researchers from the Cancer Epigenetics group led by Dr. Manel Esteller at the Josep Carreras Leukaemia Research Institute and Dr. Aurora Pujol, from the Bellvitge Biomedical Research Institute, have identified an epigenetic signature associated to the development of the Multisystem Inflammatory Syndrome in Children (MIS-C) after a SARS-CoV-2 virus infection.

27 Jun 2022

Omicron variant of SARS-CoV-2 leads to less severe disease in mouse models

Georgia State University researchers have found that the Alpha, Beta and Delta variants of SARS-CoV-2 were substantially more fatal in mouse models than the original strain of the virus that causes COVID-19.

27 Jun 2022

COVID-19 can cause metabolism problems by interfering with insulin signaling, study reveals

It has become abundantly clear that coronavirus disease 19 (COVID-19), despite being transmitted by breathing in the SARS-CoV-2 virus, can have harmful effects far beyond the lungs.

27 Jun 2022

Study investigates the virological attributes of Omicron in a Syrian hamster model

Researchers investigated the virological attributes of SARS‐CoV‐2 new variant of concern Omicron in a Syrian hamster model.

27 Jun 2022

The impact of cannabis use on COPD and COVID-19

Researchers evaluated the effects of smoking cannabis on COVID-19 test positivity.

27 Jun 2022

Mutation in SARS-CoV-2 nucleocapsid protein found to enhance replication and pathogenicity

Researchers investigated a highly variable region at residues 203 to 205 in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein.

23 Jun 2022

Speaking releases much more SARS-CoV-2 virus than breathing does

In a recent study published in the journal PNAS, researchers at the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) monitored the airborne mass of speech-generated aerosols using an alternative experimental approach that addressed issues arising from nucleated condensation.

22 Jun 2022

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

E-cigarettes have become increasingly popular among adolescents, and the latest available scientific evidence suggests the use of these products has adverse health effects that may accrue over time, leading to an increased risk of cardiovascular and pulmonary disease over the course of the life of people who use e-cigarettes, according to a new scientific statement from the American Heart Association published today in the Association's peer-reviewed journal, Circulation: Research.

21 Jun 2022

Scientists discover a direct pathway for transport of inhaled fine particles from lungs to the brain

Breathing in polluted air could lead to toxic particles being transported from lungs to brain, via the bloodstream – potentially contributing to brain disorders and neurological damage, a new study reveals.

20 Jun 2022

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Researchers assessed the characteristics of the brain fog reported by some COVID-19 patients.

17 Jun 2022

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

17 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

A new study explores the role of non-structural protein 1 (NSP1) in SARS-CoV-2 infection and pathogenesis.

16 Jun 2022

Multiomics identifies genomic risk factors for COVID-19

In a recent Cell Systems study, researchers utilized the RefMap machine learning algorithm to correlate known genomic variations for severe COVID-19 obtained from large-scale genome-wide association studies (GWAS) with single-cell multiome profiling of human lungs.

16 Jun 2022

Stanford researcher outlines pollution and climate change threats to children's health

Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

UIC scientists identify a dynamic duo of cells in lung blood vessels

Scientists at the University of Illinois Chicago have analyzed gene expression data from more than 35,000 blood vessel cells from the lungs of mice and identified two subtypes.

14 Jun 2022

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

Determining how SARS-CoV-2, the virus causing COVID-19, moves from an early stage of infection, when patients are largely asymptomatic, into a later stage when people may experience life-threatening inflammation in the lungs, is a critical step in understanding how to target and treat the disease more efficiently.

14 Jun 2022

Lungs News and Research

Penn Medicine receives $9 million to advance research on imaging technology that illuminates tumors

Researchers analyze potential of niclosamide as a SARS-CoV-2 treatment

Researchers identify an epigenetic signature associated to the development of MIS-C after COVID-19

Omicron variant of SARS-CoV-2 leads to less severe disease in mouse models

COVID-19 can cause metabolism problems by interfering with insulin signaling, study reveals

Study investigates the virological attributes of Omicron in a Syrian hamster model

The impact of cannabis use on COPD and COVID-19

Mutation in SARS-CoV-2 nucleocapsid protein found to enhance replication and pathogenicity

Speaking releases much more SARS-CoV-2 virus than breathing does

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

Scientists discover a direct pathway for transport of inhaled fine particles from lungs to the brain

Researchers investigate COVID fog and chemokine C–C motif ligand 11

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

GPR183 gene a novel drug target for severe COVID-19

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

Multiomics identifies genomic risk factors for COVID-19

Stanford researcher outlines pollution and climate change threats to children's health

Fc-effector functions for selecting COVID-19 convalescent plasma

UIC scientists identify a dynamic duo of cells in lung blood vessels

Emory researchers identify key immune cell type that drives the transition from early to late COVID-19

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News